MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (...
PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, C...
Indian Union Cabinet, chaired by Prime Minister Shri Narendra Modi, recently approved the BioE3 (Biotechnology for Economy, Environment, and Empl...
Agilent Technologies Inc., announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...
Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis...
-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...
To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...
Kiromic BioPharma, reports favorable eight-month follow-up results from the first patient enrolled in its Deltacel-01 Phase 1 clinical trial. This trial ...
Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...
JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Cli...
Primary endpoint reached in phase 2 study in which the mRNA immunotherapy candidate BNT111 is evaluated in combination with the PD-1 checkpoint inhibit...
In a recent Q&A session with BioPharma BoardRoom, Gavin Kurgan, Bioinformatics Applications Development Manager at Integrated DNA Technologies ...
NOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related disease...
Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with met...
© 2025 Biopharma Boardroom. All Rights Reserved.
